The EMA’s CHMP is undertaking a review of antifibrinolytics Media release 17 January 2013 Pages: 2 - 2
Warnings for the interaction between clopidogrel and proton pump inhibitors (PPIs) are to be updated Media release 17 January 2013 Pages: 2 - 2
Health Canada has updated the labelling for Avelox [moxifloxacin] Media release 17 January 2013 Pages: 2 - 2
The antiretrovirals tenofovir, indinavir, atazanavir and lopinavir increase the risk of chronic kidney disease (CKD) Clinical study 17 January 2013 Pages: 3 - 3
The number of reports in the WHO Adverse Drug Reaction database has hit 5 million. Media release 17 January 2013 Pages: 3 - 3
The Medicines Company is expanding its recall of Cleviprex [clevidipine] Media release 17 January 2013 Pages: 3 - 3
Rosiglitazone's risk: conflicts of interest bias conclusions Clinical study 17 January 2013 Pages: 4 - 4
Clavulanic acid may be the responsible component in immediate hypersensitivity reactions Clinical study 17 January 2013 Pages: 4 - 4
Children who receive paracetamol [acetaminophen] may be at increased risk of developing rhinitis and eczema, Clinical study 17 January 2013 Pages: 5 - 5
The basophil activation test (BAT) can diagnose immediate adverse reactions to quinolones, Clinical study 17 January 2013 Pages: 5 - 5
Long-acting insulin analogues and diabetic ketoacidosis risk Clinical study 17 January 2013 Pages: 5 - 5
Antineoplastics/granulocyte colony-stimulating factors/methylprednisolone interaction Case report 17 January 2013 Pages: 9 - 9
Chorionic gonadotropin/follicle stimulating hormone stimulants Case report 17 January 2013 Pages: 14 - 14
